HIV Vaccines
Potential Vaccine Development Announced for Worldwide Use
Published in Vaccine Weekly, July 21st, 1997
The modified version is called HGP-30W, where W stands for worldwide. It is hoped that HGP-30W will provide better worldwide protection against a large number of HIV subtypes.
Even though HIV infection is a major problem in the U.S. and Europe, the developing world has an even greater need for a protective AIDS vaccine. Due to the rapid mutation of AIDS, virtually all AIDS vaccine candidates in human testing in the U.S., if successful, would be primarily useful only against U.S. and European HIV subtypes, but much less so against Asian...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (1997-07-21)
More Articles from Vaccine Weekly
- Conference Coverage (SPIRAT/NCDDG-HIV)
Trials of HIV and HBV CTL Vaccines Underway in HIV+ Patients - Conference Coverage (SPIRAT/NCDDG-HIV)
Cyclophilin: A Cellular Target for Anti-HIV Drugs - Conference Coverage (SPIRAT/NCDDG-HIV)
HIV CTL Escape Mechanism "Bad News" For AIDS Vaccines - Bacterial Vaccines
Vaccination Could Increase Carriage of New Bacterial Serotypes - Cancer Gene Therapy
Combination Immunogene Therapy Effective In Glioblastoma Model - Immunization
Study Injects New Interest In How Vaccines Work - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
